Fears of fresh Covid wave with new JN.1 variant 'sweeping UK'

0

The new strain will likely become a ‘wave’, one infectious disease expert said (Picture: Getty Images)

The new strain will likely become a ‘wave’, one infectious disease expert said (Picture: Getty Images)

A mutated coronavirus strain better than others at evading the immune system – but not exactly good at getting inside your cells – is on the rise.

JN.1 spun off from the BA.2.86 strain, otherwise known as the Pirola variant from Omicron.

Right now, it only makes up a small fraction of global coronavirus cases, circling a dozen or so countries.

But British health chiefs designated it as an official variant this week, labelling it V-23DEC-01, so they can track the virus ahead of the holidays.

JN.1 first entered the radars of the UK Health Security Agency (UKHSA) in late October as part of routine monitoring, the agency said yesterday.

As of Monday, about 302 cases of JN.1 coronavirus have been detected, the vast majority in England at 223, with 3,618 picked up internationally.

Expectant mother watches as tech gives her vaccine

Most Britons now have some form of immunity to the once-novel coronavirus (Picture: Getty Images)

Though public health officials admit the true number is likely far higher, with only a fraction of sick patients now tested.

Just last month, JN.1 amounted to about 7.9% of all Covid-19 cases in England, with a weekly estimated growth rate advantage of 84.2%, Dr Meaghan Kall, an epidemiologist at the UKHSA, said on X.

Hall stressed, however, that while this suggests the strain is surging faster than any other in at least eight months, it’s hard to compare to growth rates before March as scientists have changed how they keep tabs on variants.

‘It seems likely we must now add variant pressures to the forecast of a winter Covid-19 wave,’ she said.

‘What is reassuring is that a lot of characterisation work was done for BA.2.86 so we are not totally in the dark about this variant.’

In October, Chinese scientists released new data that JN.1 is better adapted than other variants at swerving antibodies, the body’s, well, bodyguards.

But Yunlong Richard Cao, an assistant professor at Beijing’s Peking University Biomedical Pioneering Innovation Center, said on X that this comes ‘at the cost of ACE2 binding’.

Like a key being inserted into a lock, the Covid virus uses its spike-like protein to pierce the surface of a cell, called ACE2, allowing it to infect people.

This means that while JN.1 is more resistant, it’s not the best at actually infecting people.

Get in touch with our news team by emailing us at [email protected].

For more stories like this, check our news page.

Stay connected with us on social media platform for instant update click here to join our  Twitter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Covid-19 News Click Here 

Read original article here

Denial of responsibility! Rapidtelecast.com is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
Leave a comment